title: Continuation of immunosuppressive treatment may be necessary in IgA nephropathy patients with remission of proteinuria: Evaluation by repeat renal biopsy.
abstract: The present study aimed to evaluate the effects of an individualized, low-dose multi-drug immunosuppressive regimen for the treatment of immunoglobulin A nephropathy (IgAN). A preliminary investigation of the course of IgAN following immunosuppressive treatment was conducted based on repeat renal biopsies. Clinical and pathological data of 17 patients with IgAN who received repeat renal biopsies were analyzed retrospectively. In addition to basic treatment, 16 patients regularly received an individualized low-dose immunosuppressive regimen according to their clinical manifestations and pathological patterns following the first biopsy. Clinical parameters, including 24-h urinary protein excretion and levels of serum albumin, uric acid and total cholesterol were collected. Glomerular deposits of IgA and C3, as well as the activity and chronicity indexes of renal lesions were evaluated by semi-quantitative methods. The 24-h urinary protein excretion of the patients decreased significantly from the first biopsy (2.53±2.17 g/day) to the repeated biopsy (0.26±0.55 g/day) (P<0.001). Deposits of IgA and C3 in the glomerulus were persistent, but were reduced in quantity at the second biopsy. Although active renal lesions were observed in the majority of patients, the activity index decreased significantly from 3.18±1.33 prior to therapy to 2.47±0.80 following therapy (P<0.05), while the chronicity index did not change significantly (2.59±2.00 versus 2.76±1.89, respectively). The individualized, low-dose multi-drug immunosuppressive regimen used in the present study significantly minimized proteinuria, stabilized renal function and alleviated histological lesions in patients with IgAN without causing overt adverse effects during the short-term follow-up. In addition to proteinuria, renal pathological changes should be appraised when considering the withdrawal of immunosuppressants from IgAN treatment.
authors: Institute of Nephrology, Guangdong Medical College, Zhanjiang, Guangdong 524001, P.R. China.
authors: Mian-Na
authors: MN
authors: Luo
authors: Institute of Nephrology, Guangdong Medical College, Zhanjiang, Guangdong 524001, P.R. China.
authors: Cui-Wei
authors: CW
authors: Yao
authors: Institute of Nephrology, Guangdong Medical College, Zhanjiang, Guangdong 524001, P.R. China.
authors: Bi-Hua
authors: BH
authors: Xu
authors: Institute of Nephrology, Guangdong Medical College, Zhanjiang, Guangdong 524001, P.R. China.
authors: Yong-Zhi
authors: YZ
authors: Xu
authors: Institute of Nephrology, Guangdong Medical College, Zhanjiang, Guangdong 524001, P.R. China.
authors: Wei Jing
authors: WJ
authors: Liu
authors: Institute of Nephrology, Guangdong Medical College, Zhanjiang, Guangdong 524001, P.R. China.
authors: Yong-Min
authors: YM
authors: Feng
authors: Institute of Nephrology, Guangdong Medical College, Zhanjiang, Guangdong 524001, P.R. China.
authors: Jing-Li
authors: JL
authors: Tao
authors: Institute of Nephrology, Guangdong Medical College, Zhanjiang, Guangdong 524001, P.R. China.
authors: Hua-Feng
authors: HF
authors: Liu
keywords: course of treatment; immunoglobulin A nephropathy; immunosuppressive treatment; proteinuria; renal pathology